The U.S. Supreme Court's decision in Ruan v. U.S., demanding rock-solid proof of intentional impropriety to convict a prescriber under the Controlled Substances Act, provides reassurance to opioid prescribers, but the U.S. Department of Justice is unlikely to back down on CSA prosecutions, say Janelle Pelli and Michelle Peirce at Hinckley Allen.